These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2093117)

  • 1. Preclinical antimycotic activity of SDZ 89-485: a new orally and topically effective triazole.
    Schaude M; Petranyi G; Ackerbauer H; Meingassner JG; Mieth H
    J Med Vet Mycol; 1990; 28(6):445-54. PubMed ID: 2093117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro antifungal spectrum of itraconazole and treatment of systemic mycoses with old and new antimycotic agents.
    Van Cutsem J
    Chemotherapy; 1992; 38 Suppl 1():3-11. PubMed ID: 1319313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimycotic activity of BAY N 7133 in animal experiments.
    Plempel M
    J Antimicrob Chemother; 1984 May; 13(5):447-63. PubMed ID: 6330018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxiconazole, a new imidazole derivative. Evaluation of antifungal activity in vitro and in vivo.
    Polak A
    Arzneimittelforschung; 1982; 32(1):17-24. PubMed ID: 7037014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo efficacy of SM-8668 (Sch 39304), a new oral triazole antifungal agent.
    Tanio T; Ichise K; Nakajima T; Okuda T
    Antimicrob Agents Chemother; 1990 Jun; 34(6):980-4. PubMed ID: 2203310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T-8581, a new orally and parenterally active triazole antifungal agent: in vitro and in vivo evaluations.
    Yotsuji A; Shimizu K; Araki H; Fujimaki K; Nishida N; Hori R; Annen N; Yamamoto S; Hayakawa H; Imaizumi H; Watanbe Y; Narita H
    Antimicrob Agents Chemother; 1997 Jan; 41(1):30-4. PubMed ID: 8980750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Azole resistance in Candida albicans.
    Smith KJ; Warnock DW; Kennedy CT; Johnson EM; Hopwood V; Van Cutsem J; Vanden Bossche H
    J Med Vet Mycol; 1986 Apr; 24(2):133-44. PubMed ID: 3014106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo antifungal activities of TAK-456, a novel oral triazole with a broad antifungal spectrum.
    Tsuchimori N; Hayashi R; Kitamoto N; Asai K; Kitazaki T; Iizawa Y; Itoh K; Okonogi K
    Antimicrob Agents Chemother; 2002 May; 46(5):1388-93. PubMed ID: 11959573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity of SM-4470, a new imidazole derivative, against experimental fungal infections.
    Ichise K; Tanio T; Saji I; Okuda T
    Antimicrob Agents Chemother; 1986 Sep; 30(3):366-9. PubMed ID: 3777903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo antifungal activities of FX0685, a novel triazole antifungal agent with potent activity against fluconazole-resistant Candida albicans.
    Takahata S; Okutomi T; Ohtsuka K; Hoshiko S; Uchida K; Yamaguchi H
    Med Mycol; 2005 May; 43(3):227-33. PubMed ID: 16010849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity of orally, topically, and parenterally administered itraconazole in the treatment of superficial and deep mycoses: animal models.
    Van Cutsem J; Van Gerven F; Janssen PA
    Rev Infect Dis; 1987; 9 Suppl 1():S15-32. PubMed ID: 3027843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral, topical and parenteral antifungal treatment with itraconazole in normal and in immunocompromised animals.
    Van Cutsem J
    Mycoses; 1989; 32 Suppl 1():14-34. PubMed ID: 2561183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo activities of SCH 42427, the active enantiomer of the antifungal agent SCH 39304.
    Loebenberg D; Cacciapuoti A; Parmegiani R; Moss EL; Menzel F; Antonacci B; Norris C; Yarosh-Tomaine T; Hare RS; Miller GH
    Antimicrob Agents Chemother; 1992 Feb; 36(2):498-501. PubMed ID: 1605621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guideline: vulvovaginal candidosis (AWMF 015/072), S2k (excluding chronic mucocutaneous candidosis).
    Mendling W; Brasch J; Cornely OA; Effendy I; Friese K; Ginter-Hanselmayer G; Hof H; Mayser P; Mylonas I; Ruhnke M; Schaller M; Weissenbacher ER
    Mycoses; 2015 Mar; 58 Suppl 1():1-15. PubMed ID: 25711406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of NND-502, a novel imidazole antimycotic agent, in experimental models of Candida albicans and Aspergillus fumigatus infections.
    Niwano Y; Kuzuhara N; Goto Y; Munechika Y; Kodama H; Kanai K; Yoshida M; Miyazaki T; Yamaguchi H
    Int J Antimicrob Agents; 1999 Aug; 12(3):221-8. PubMed ID: 10461840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of ER-30346, a novel oral triazole antifungal agent, in experimental models of aspergillosis, candidiasis, and cryptococcosis.
    Hata K; Kimura J; Miki H; Toyosawa T; Moriyama M; Katsu K
    Antimicrob Agents Chemother; 1996 Oct; 40(10):2243-7. PubMed ID: 8891122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical mode of action and enantiomeric selectivity of SDZ 89-485, a new triazole antimycotic.
    Ryder NS
    J Med Vet Mycol; 1990; 28(5):385-94. PubMed ID: 2283585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sch 39304, a new antifungal agent: oral and topical treatment of vaginal and superficial infections.
    Parmegiani RM; Loebenberg D; Cacciapuoti A; Antonacci B; Norris C; Menzel F; Moss L; Yarosh-Tomaine T; Hare RS; Miller GH
    J Med Vet Mycol; 1993; 31(3):239-48. PubMed ID: 8360815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo activities of syn2836, syn2869, syn2903, and syn2921: new series of triazole antifungal agents.
    Salama SM; Atwal H; Gandhi A; Simon J; Poglod M; Montaseri H; Khan JK; Furukawa T; Saito H; Nishida K; Higashitani F; Uji T; Unemi N; Daneshtalab M; Micetich RG
    Antimicrob Agents Chemother; 2001 Sep; 45(9):2420-6. PubMed ID: 11502508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activities of an intravenous formulation of itraconazole in experimental disseminated Aspergillus, Candida, and Cryptococcus infections.
    Odds FC; Oris M; Van Dorsselaer P; Van Gerven F
    Antimicrob Agents Chemother; 2000 Nov; 44(11):3180-3. PubMed ID: 11036047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.